Form 4 for TDOC Teladoc Health, Inc.
Accepted 2025-03-21 00:00:00 ET · period of report 2025-03-19 · accession 0001477449-25-000031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-21 | 2025-03-20 | TDOC | Bliss Kelly | Pres, U.S. Group Health | S - Sale+OE | $8.42 | -9,470 | 45.4K | -17% | -$79.7K |
| D | 2025-03-21 | 2025-03-19 | TDOC | Bliss Kelly | Pres, U.S. Group Health | M - OptEx | — | +19.4K | 54.9K | +55% | — |
| D | 2025-03-21 | 2025-03-19 | TDOC | Bliss Kelly | Pres, U.S. Group Health | M - OptEx | $0.00 | -19.4K | 38.9K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-20 | S | D | 9,470 | $8.42 | 45,384 | D | — | — | (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. |
| 2 | Common | Common Stock | 2025-03-19 | M | A | 19,433 | — | 54,854 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 3 | Derivative | Restricted Stock Units | 2025-03-19 | M | D | 19,433 | $0.00 | 38,867 | D | — · — to — | 19,433 Common Stock | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |